Clinical trial
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients…
NCT00367991 · Yale University, Other · Completed
Key facts
| NCT number | NCT00367991 |
|---|---|
| Title | Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction |
| Official title | Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction |
| Lead sponsor | Yale University, Other |
| Collaborators | American Heart Association |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Recombinant human erythropoietin alfa (drug), Placebo |
| Enrollment | 44 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 24, 2006 |
| Last update posted | Jan 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: